hotspot -WSS

hotspot

author：hotspot 2025-10-02 22:00:34 - browse：83

Elizabeth Warren speaks behind a podium with a sign that reads "ABORTION RIGHTS FOR ALL" — Sen. Elizabeth Warren (D-Mass.) J. Scott Applewhite/AP

WASHINGTON — Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’ limits to abortion rights as a battle on medication abortion hangs in the balance at a federal court.

Warren and three other Democratic senators sent letters late last week to five major health care worker and pharmacy groups interrogating how last year’s U.S. Supreme Court decision reversing national abortion rights has affected health care access and providers’ treatment of patients.

It’s not the first time the Massachusetts Democrat has aimed questions at these organizations, which include the American Medical Association, Physicians for Reproductive Health, National Nurses United, the American Pharmacists Association, and the American Hospital Association. She asked the same set of groups last summer how the U.S. Supreme Court’s overturn of Roe v. Wade impacted women’s health care, and reported in October that the groups warned about “diminished access” to pregnancy care and abortion bans that “will exacerbate existing health inequities.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： First medicine developed to treat MASH expected to be approved soon

focus

WSS

How to make the FDA’s new prescription one

New Covid vaccine is recommended for everyone 6 months or older

How medical schools plan to diversify without affirmative action

Pig kidney works a record two months in donated body

First medicine developed to treat MASH expected to be approved soon

First medicine developed to treat MASH expected to be approved soon

leisure time

hotspot

focus

Medicare details structure of new drug price negotiation program

WATCH: Why do bright lights make us see spots?

Bright Health sells Medicare Advantage business to Molina

Change Healthcare cyberattack prompts Medicare loan program

Wildfire smoke exposes gaps in outdoor worker protections

Private equity could exacerbate cardiology's overuse problem, experts fear

Psychedelics group wrestles with new pharma identity

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Malaria cases in Florida and Texas: Here’s what you need to know

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

entertainment

First medicine developed to treat MASH expected to be approved soon

Food makers tried to stack nutrition panel with preferred experts

New weight loss drugs vying to be the next Wegovy or Mounjaro

Sen. Paul opposes bill to ban Chinese biotechs

How housing is health care on Long Island

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Wikipedia

focus

focus

leisure time